摘要
OBJECTIVE: To investigate the protective effects and underlying mechanism of Qingdu decoction(QDD) on experimental rats with severe liver injury induced by thioacetamide(TAA).METHODS: A total of 40 Wistar rats were randomly divided into normal group(n = 10) and experimental group(n = 30). Rats were administrated the same content of saline in normal group. The rats inthe experimental group were pretreated with TAA at dose of 12 mg/kg lasting 8 weeks, and from 9th week to 12 th week, with TAA at concentration of 36mg/kg. During the 9th week to 12 th week period,the rats were randomly divided into three subgroups(n = 10 each) simultaneously based on the treatment categories: model group, lactulose(LA,3.5 m L/kg) group and QDD(5.95 g/kg) group, orally once per day respectively. At the 12 th week, the content of serum alanine transaminase(ALT), aspartate transaminase(AST), total bilirubin(TBIL), endotoxin(ET) and tumor necrosis factor α(TNF-α) was detected by automatic biochemical analyzer. The plasma prothrombin time(PT), prothrombin time-international normalized ratio(PTR) and prothrombin time activity(PTA) were measured by automatic coagulation analyzer. The level of lipopolysaccharide(LPS)-binding protein(LBP), cluster differentiation 14(CD14) and Toll-like receptor 4(TLR4) expressions was measured by both western blot(WB) and real-time polymerase chain reaction(real-time PCR).RESULTS: Compared with the model group, hepatic morphology in the QDD group was improved under light microscope and transmission electron microscope; at the same time, the contents of serum ALT, AST, TBIL, ET and TNF-α, and level of LBP, CD14 and TLR4 expressions in liver tissues were significantly decreased compared with the model group(P < 0.05), while PTA in the QDD group was enhanced(P < 0.05).CONCLUSION: QDD has the functional effect on improving the injured liver through inhibiting the LPS/TLR4 signaling pathway thus decreasing the level of the inflammatory medicators.
OBJECTIVE： To investigate the protective effects and underlying mechanism of Qingdu decoction（QDD） on experimental rats with severe liver injury induced by thioacetamide（TAA）.METHODS： A total of 40 Wistar rats were randomly divided into normal group（n = 10） and experimental group（n = 30）. Rats were administrated the same content of saline in normal group. The rats inthe experimental group were pretreated with TAA at dose of 12 mg/kg lasting 8 weeks, and from 9th week to 12 th week, with TAA at concentration of 36mg/kg. During the 9th week to 12 th week period,the rats were randomly divided into three subgroups（n = 10 each） simultaneously based on the treatment categories： model group, lactulose（LA,3.5 m L/kg） group and QDD（5.95 g/kg） group, orally once per day respectively. At the 12 th week, the content of serum alanine transaminase（ALT）, aspartate transaminase（AST）, total bilirubin（TBIL）, endotoxin（ET） and tumor necrosis factor α（TNF-α） was detected by automatic biochemical analyzer. The plasma prothrombin time（PT）, prothrombin time-international normalized ratio（PTR） and prothrombin time activity（PTA） were measured by automatic coagulation analyzer. The level of lipopolysaccharide（LPS）-binding protein（LBP）, cluster differentiation 14（CD14） and Toll-like receptor 4（TLR4） expressions was measured by both western blot（WB） and real-time polymerase chain reaction（real-time PCR）.RESULTS： Compared with the model group, hepatic morphology in the QDD group was improved under light microscope and transmission electron microscope; at the same time, the contents of serum ALT, AST, TBIL, ET and TNF-α, and level of LBP, CD14 and TLR4 expressions in liver tissues were significantly decreased compared with the model group（P 〈 0.05）, while PTA in the QDD group was enhanced（P 〈 0.05）.CONCLUSION： QDD has the functional effect on improving the injured liver through inhibiting the LPS/TLR4 signaling pathway thus decreasing the level of the inflammatory medicators.
基金
Supported by Beijing Natural Science Foundation of China(Investigation of the Mechanism on Qingdu Decoction in Repairing Injured Liver with TAA in Rat Based on Decreasing Intestinal Permeability,No.7142023)
